Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno <i>et al</i>.

Liew, Jean W; Graef, Elizabeth R; Sparks, Jeffrey A; Kim, Alfred Hyoungju

Response to: 'Emergency arising from patients' fear of taking antimalarials during these COVID-19 times: are antimalarials as unsafe for cardiovascular health as recent reports suggest?' by Santos-Moreno et al.

Liew, Jean W; Graef, Elizabeth R; Sparks, Jeffrey A; Kim, Alfred Hyoungju.

Liew JW; Division of Rheumatology, Boston University, Boston, Massachusetts, USA.
Graef ER; Division of Rheumatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Sparks JA; Department of Medicine, Division of Rheumatology, Inflammation, and Immunity, Brigham and Women's Hospital, Boston, Massachusetts, USA jsparks@bwh.harvard.edu.
Kim AH; Medicine/Rheumatology, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri, USA.

Ann Rheum Dis ; 81(8): e155, 2022 08.

Article in English | MEDLINE | ID: covidwho-640167

Subject(s)

Antimalarials; COVID-19; Antimalarials/adverse effects; Chloroquine; Fear; Humans; Hydroxychloroquine/adverse effects

Keywords

antirheumatic agents; cardiovascular diseases; hydroxychloroquine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antimalarials Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Annrheumdis-2020-218432

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google